Global Prostate Biopsy Market 2017-2021

前立腺生検の世界市場2017-2021:針生検、液体生検

◆タイトル:Global Prostate Biopsy Market 2017-2021
◆商品コード:IRTNTR11999
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年2月16日
◆ページ数:97
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:世界
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、前立腺生検の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、前立腺生検の世界市場規模及び予測、製品別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Prostate Biopsy Market Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments.

Technavio’s analysts forecast the global prostate biopsy market to grow at a CAGR of 12.66% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global prostate biopsy market for 2017-2021. To calculate the market size, the report considers the new sales of devices and products used in prostate biopsy

The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC

Technavio’s report, Global Prostate Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• C.R. Bard
• Cook Medical
• Endomed Systems
• SOMATEX Medical Technologies
• Biomedical

[Other prominent vendors]
• Amecath
• AprioMed
• Argon Medical Devices
• Biopsybell
• Boston Scientific
• Exosome Diagnostics
• MDNA Life Sciences
• MDxHealth
• Möller Medical
• Pathway Genomics
• Predicine
• Sterylab
• TSK Laboratory Europe
• UroMed
• Urotech

[Market driver]
• Growing incidences of prostate cancer
• For a full, detailed list, view our report

[Market challenge]
• Complications associated with prostate needle biopsies
• For a full, detailed list, view our report

[Market trend]
• New product launches and R&D activities
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents

PART 01: Executive summary 

PART 02: Scope of  the report 

PART 03: Research Methodology 

PART 04: Introduction 

Key market highlights 
Prostate cancer: An overview 

PART 05: Market landscape 

Market overview 
Market size and forecast 
Five forces analysis 

PART 06: Market segmentation by product 

Market overview 
Global prostate needle biopsy market 
Global prostate liquid biopsy market 

PART 07: Market segmentation by end-user 

Hospitals 
ASCs 
Diagnostic centers 
Key buying criteria 

PART 08: Geographical segmentation 

Prostate biopsy market in Americas 
Prostate biopsy market in EMEA 
Prostate biopsy market in APAC 

PART 09: Market drivers 

Growing incidences of prostate cancer 
Recurrent revenue from repeat biopsy tests 
Growing number of diagnostic centers 

PART 10: Impact of drivers 

PART 11: Market challenges 

Complications associated with prostate needle biopsies 
High cost of biopsy procedure 
Inaccurate test results 
Limited technical skills 

PART 12: Impact of drivers and challenges 

PART 13: Market trends 

New product launches and R&D activities 
Growing demand for MRI and Ultrasound guided prostate biopsy procedures 
High growth potential of prostate liquid biopsy tests 
Growing focus toward combination of traditional and liquid biopsy tests 

PART 14: Vendor landscape 

Competitive scenario 

PART 15: Key vendor analysis 

C.R. Bard 
Cook Medical 
Endomed Systems 
SOMATEX Medical Technologies 
Biomedical 
Other prominent vendors 

PART 16: Appendix 

List of abbreviations 

PART 17: Explore Technavio 

[List of Exhibits]

Exhibit 01: Incidence rate of prostate cancer in different age groups 2015 

Exhibit 02: Stages of prostate cancer and various diagnostics tools used for detection 

Exhibit 03: Snapshot of global prostate biopsy market 

Exhibit 04: Global prostate biopsy market 2016-2021 ($ millions) 

Exhibit 05: Prostate cancer: Key statistics 

Exhibit 06: Global prostate biopsy market analysis: Developed and emerging markets 

Exhibit 07: Five forces analysis 

Exhibit 08: Segmentation of global prostate biopsy market by product type 

Exhibit 09: Two most common biopsies for prostate cancer 

Exhibit 10: Share of each product type in the global prostate biopsy market 2016 and 2021 (%) 

Exhibit 11: Global prostate biopsy market by product analysis 2016 

Exhibit 12: Global prostate biopsy market: Lifecycle analysis 2016 

Exhibit 13: Segmentation of global prostate biopsy market by product 2016-2021 ($ millions) 

Exhibit 14: Segmentation of global prostate biopsy market by product 2016-2021 (%) 

Exhibit 15: Global prostate needle biopsy market 2016-2021 ($ millions) 

Exhibit 16: Types of prostate biopsy devices 

Exhibit 17: Types of prostate biopsy guns 

Exhibit 18: Percentage share of reusable and disposable prostate biopsy guns 2016 

Exhibit 19: Benefits of advanced biopsy needles 

Exhibit 20: Global prostate needle biopsy market segmentation percentage split 2016 

Exhibit 21: Global prostate liquid biopsy market 2016-2021 ($ millions) 

Exhibit 22: Global prostate biopsy market by end-user 2016 (%) 

Exhibit 23: Factors affecting the purchase decision of prostate biopsy devices 

Exhibit 24: Global prostate biopsy market segmentation by geography 2016-2021 (%) 

Exhibit 25: Global prostate biopsy market analysis by geography 2016 

Exhibit 26: Global prostate biopsy market: Geography market growth lifecycle analysis 2016 

Exhibit 27: Country wise presence of global prostate biopsy market 

Exhibit 28: Geographical overview of global prostate biopsy market 2016-2021 

Exhibit 29: Prostate biopsy market in Americas 2016-2021 ($ millions) 

Exhibit 30: Prostate biopsy market in EMEA 2016-2021 ($ millions) 

Exhibit 31: Prostate biopsy market in APAC 2016-2021 ($ millions) 

Exhibit 32: Global prostate biopsy market by geography 2016-2021 ($ millions) 

Exhibit 33: Global prostate biopsy market by geography 2016-2021 (%) 

Exhibit 34: Impact of drivers 

Exhibit 35: Cost of biopsies for uninsured people in US, 2015 

Exhibit 36: Impact of drivers and challenges 

Exhibit 37: Competitive structure analysis of global prostate biopsy market 2016 

Exhibit 38: Competitive parameters in global prostate biopsy market 

Exhibit 39: C.R. Bard strength assessment 

Exhibit 40: C.R. Bard strategy assessment 

Exhibit 41: C.R. Bard opportunity assessment 

Exhibit 42: Key highlights of Cook Medical 

Exhibit 43: Cook Medical strength assessment 

Exhibit 44: Cook Medical strategy assessment 

Exhibit 45: Cook Medical opportunity assessment 

Exhibit 46: Endomed Systems strength assessment 

Exhibit 47: Endomed Systems strategy assessment 

Exhibit 48: Endomed Systems opportunity assessment 

Exhibit 49: Key highlights of SOMATEX Medical Technologies 

Exhibit 50: SOMATEX Medical Technologies strength assessment 

Exhibit 51: SOMATEX Medical Technologies strategy assessment 

Exhibit 52: SOMATEX Medical Technologies opportunity assessment 

Exhibit 53: Key highlights of Biomedical 

Exhibit 54: Biomedical strength assessment 

Exhibit 55: Biomedical strategy assessment 

Exhibit 56: Biomedical opportunity assessment  



【資料のキーワード】

前立腺生検、前立腺針生検、前立腺液体生検、前立腺生検検査

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[前立腺生検の世界市場2017-2021:針生検、液体生検] (Global Prostate Biopsy Market 2017-2021 / IRTNTR11999)販売に関する免責事項
[前立腺生検の世界市場2017-2021:針生検、液体生検] (Global Prostate Biopsy Market 2017-2021 / IRTNTR11999)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆